Literature DB >> 18192700

DDD(R)-pacing, but not AAI(R)-pacing induces left ventricular desynchronization in patients with sick sinus syndrome: tissue-Doppler and 3D echocardiographic evaluation in a randomized controlled comparison.

Andi Eie Albertsen1, Jens Cosedis Nielsen, Steen Hvitfeldt Poulsen, Peter Thomas Mortensen, Anders Kirstein Pedersen, Peter Steen Hansen, Henrik Kjaerulf Jensen, Henrik Egeblad.   

Abstract

AIMS: Increasing evidence from randomized trials and experimental studies indicates that right ventricular (RV) pacing may induce congestive heart failure. We studied regional left ventricular (LV) dyssynchrony and global LV function in 50 consecutive patients with sick sinus syndrome (SSS) randomized to either atrial pacing [AAI(R)] or dual chamber RV-pacing [DDD(R)]. METHODS AND
RESULTS: Fifty consecutive patients were randomized to AAI(R) or DDD(R)-pacing. Tissue-Doppler imaging was used to quantify LV dyssynchrony in terms of number of segments with delayed longitudinal contraction (DLC). Left ventricular ejection fraction (LVEF) was measured using three-dimensional echocardiography. Dyssynchrony was more pronounced in the DDD(R)-group than in the AAI(R)-group at the 12 months follow-up (P < 0.05). This reflected a significant increase of dyssynchrony in the DDD(R)-group from baseline to the 12 months follow-up (1.3 +/- 1 to 2.1 +/- 1 segments displaying DLC per patient), P < 0.05. No change was observed in the AAI(R)-group (1.6 +/- 2 to 1.3 +/- 2 segments displaying DLC per patient, NS). No difference in LVEF, NYHA or NT-proBNP was observed between AAI(R)- and DDD(R)-mode after 12 months of pacing although LVEF decreased significantly in the DDD(R)-group from baseline (63.1 +/- 8%) to the 12 months follow-up (59.3 +/- 8%, P < 0.05), while LVEF remained unchanged in the AAI(R)-group (61.5 +/- 11% at baseline vs. 62.3 +/- 7% after 12 months, NS.
CONCLUSION: In patients with SSS, DDD(R)-pacing but not AAI(R)-pacing induces significant LV desynchronization and reduction of LVEF.

Entities:  

Mesh:

Year:  2008        PMID: 18192700     DOI: 10.1093/europace/eum279

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  7 in total

1.  Nonpharmacological Treatment of Atrial Fibrillation: What Is the Role of Device Therapy?

Authors:  Lucie Riedlbauchová; Václav Durdil; Jakub Honěk; Josef Veselka
Journal:  Int J Angiol       Date:  2020-04-28

Review 2.  Cardiac pacing strategies and post-implantation risk of atrial fibrillation and heart failure events in sinus node dysfunction patients: a collaborative analysis of over 6000 patients.

Authors:  Shaojie Chen; Zhenglong Wang; Marcio Galindo Kiuchi; Bruno Rustum Andrea; Mitchell W Krucoff; Shaowen Liu; Helmut Pürerfellner
Journal:  Clin Res Cardiol       Date:  2016-02-25       Impact factor: 5.460

3.  The tissue velocity imaging and strain rate imaging in the assessment of interatrial electromechanical conduction in patients with sick sinus syndrome before and after pacemaker implantation.

Authors:  Xiaozhi Zheng; Ping Ji; Hongwei Mao; Jianqun Hu
Journal:  Bosn J Basic Med Sci       Date:  2011-05       Impact factor: 3.363

4.  [Maintenance of AAI(R) mode at the time of generator replacement].

Authors:  E Wunderlich; H Schindler; A Hetze; C Wunderlich
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2010-09

Review 5.  Right Ventricular Versus Biventricular Pacing for Heart Failure and Atrioventricular Block.

Authors:  Hiroko Beck; Anne B Curtis
Journal:  Curr Heart Fail Rep       Date:  2016-10

6.  Comparison of ventricular dyssynchrony according to the position of right ventricular pacing electrode: a multi-center prospective echocardiographic study.

Authors:  Goo-Yeong Cho; Mi-Jeong Kim; Jae-Hyeong Park; Hyun-Sook Kim; Hyun Ju Youn; Kye-Hun Kim; Jae-Kwan Song
Journal:  J Cardiovasc Ultrasound       Date:  2011-03-31

7.  Acute impact of pacing at different cardiac sites on left ventricular rotation and twist in dogs.

Authors:  Zhi-Wen Zhou; Bu-Chun Zhang; Yi Yu; Kai Guo; Wei Li; Rui Zhang; Peng-Pai Zhang; Yi-Gang Li
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.